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Abstract
Introduction:  hematopoietic  stem  cell  transplantation  (HSCT)  is  associated  with  more  respira-
tory infections  due  to  immunosuppression.
Objective:  this  study  aimed  to  verify  the  frequency  of  rhinosinusitis  after  HSCT,  and  the
association  between  rhinosinusitis  and  chronic  graft  vs.  host  disease  (GVHD)  and  type  of  trans-
plantation,  clinical  treatment,  surgical  treatment,  and  survival.
Methods:  this  was  a  retrospective  study  in  a  tertiary  university  hospital.  A  total  of  95  patients
with hematological  diseases  undergoing  HSCT  between  1996  and  2011  were  selected.
Results: chronic  myeloid  leukemia  was  the  most  prevalent  disease.  The  type  of  transplant  most
often performed  was  the  allogenic  type  (85.26%).  The  frequency  of  rhinosinusitis  was  36%,  with
no difference  between  the  autologous  and  the  allogenic  types.  Chronic  GVHD  occurred  in  30%
of patients.  Patients  with  GVHD  had  a  higher  frequency  and  recurrence  of  rhinosinusitis,  in
addition  to  more  frequent  need  for  endoscopic  sinusectomy  and  decreased  overall  survival.
Conclusion:  there  was  a  higher  frequency  of  rhinosinusitis  in  HSCT  and  GVHD.  The  type  of
transplant  does  not  appear  to  predispose  to  the  occurrence  of  rhinosinusitis.  GVHD  seems  to  be
an aggravating  factor  and  requires  a  more  stringent  treatment.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Afecc¸ões  nasossinusais  em  pacientes  transplantados  de  células-tronco
hematopoiéticas
Resumo
Introduc¸ão:  O  transplante  de  células  troncas  hematopoiéticas  (TCTH)  associa-se  a  mais
infecc¸ões respiratórias  devido  a  imunossupressão.
Objetivo:  Este  trabalho  tem  o  objetivo  de  verificar  a  frequência  das  rinossinusites  pós-TCTH,
a associac¸ão  entre  a  rinossinusite  e  a  doenc¸a  do  enxerto  contra  hospedeiro  (DECH)  crônico  e  o
tipo de  transplante  e  o  tratamento  clinico  e  o  tratamento  cirúrgico  e  a  sobrevida.
Método:  Estudo  retrospectivo  em  hospital  universitário  terciário.  Foram  selecionados  95
pacientes  com  doenc¸a  hematológica  submetidos  a  TCTH  entre  1996  a  2011.
Resultados:  A  leucemia  mieloide  crônica  foi  a  doenc¸a  mais  prevalente.  O  tipo  de  transplante
mais realizado  foi  o  alogênico  (85,26%).  A  frequência  de  rinossinusite  foi  de  36%,  sem  diferenc¸a
entre os  tipos  de  transplante  autólogo  e  alogênico.  A  DECH  crônica  ocorreu  em  30%  dos
pacientes. Os  pacientes  com  DECH  tiveram  maior  frequência  e  recorrência  de  rinossinusite,
além de  mais  necessidade  de  sinusectomia  endoscópica  e  de  diminuic¸ão  da  sobrevida  global.
Conclusão: Houve  maior  frequência  de  rinossinusite  no  TCTH  e  DECH.  O  tipo  de  transplante
não parece  predispor  a  ocorrência  da  rinossinusite.  A  DECH  parece  ser  um  fator  agravante  e
necessita  de  tratamento  mais  rigoroso.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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alterations  in  the  computed  tomography  (CT)  scan  of  thentroduction
urrently,  hematopoietic  stem  cell  transplantation  (HSCT)  is
sed  in  most  tertiary  hospitals  for  treatment  of  hematologic
alignant  and  non-malignant  diseases,  immunodeficiencies,
nd  solid  tumors.1--5 The  number  of  transplantations  progres-
ively  increases  with  the  improvement  and  modernization  of
echniques  and  drugs  used.  In  Brazil,  approximately  12,287
ransplantations  were  performed  in  the  latter  half  of  2012.6
In  spite  of  advances  in  the  transplantation  process,
atients  are  still  predisposed  to  multiple  upper  airway
nfections  and  their  complications.1--5,7,8 Immunosuppressive
rugs,  chemotherapy,  radiation  therapy,  prolonged  antibi-
tic  therapy,  graft  vs.  host  disease  (GVHD),  and  long
eriods  of  hospitalization  are  predisposing  factors  for  air-
ay  infections  described  in  the  literature  and  observed  in
he  everyday  life  of  these  patients.1--5,7,8
It  is  believed  that  immunosuppression  is  obviously  the
ain  triggering  factor  of  such  infections,  since  the  air-
ay  is  the  location  most  exposed  to  the  environment  and
ts  microorganisms.  However,  studies  have  demonstrated  a
igher  prevalence  and  recurrence  of  rhinosinusitis  in  trans-
lanted  patients  with  GVHD.5,7,8 There  is  evidence  that
lterations  in  the  ultrastructure  and  on  the  surface  of  the
espiratory  epithelium  occur,  as  well  as  immunosuppression.
herefore,  in  addition  to  the  absence  of  immune  protection,
here  is  an  alteration  on  the  surface  and  in  the  mucociliary
learance,  increasing  the  vulnerability  to  airway  infections
n  these  patients.9,10
Supplementary  examinations  greatly  assist  in  the  diagno-
is  of  rhinosinusitis  in  transplanted  patients,  especially  nasal
ndoscopy.4,5,7,8 Computed  tomography  is  used  primarily  to
lan  the  surgical  treatment;  however,  it  does  not  appear  to
e  useful  to  predict  the  occurrence  of  rhinosinusitis  after
ransplantation.11--14
p
t
tIsolation  of  the  infectious  microorganism  through  cul-
ures  or  by  direct  screening  is  important  to  determine  the
rug  therapy  and  even  the  surgical  treatment,  due  to  the
xistence  of  more  diversified  and  resistant  microorganisms,
ncluding  fungi.4,5,7
The  treatment  of  rhinosinusitis  in  transplanted  patients
ust  be  established  more  promptly  and  should  involve  the
se  of  broad-spectrum  antibiotics  for  a  long  period.2--5,7,8,10
ore  predisposed  patients,  such  as  those  with  GVHD,
re  candidates  to  endoscopic  sinusectomy  in  recurrent
hinosinusitis.4,5,7,15
This  study  aimed  to  analyze,  firstly,  the  profile  of  patients
reated  in  this  department  by  assessing  the  frequency
f  rhinosinusitis  after  HSCT,  and  secondly,  the  association
etween  rhinosinusitis,  GVHD,  the  type  of  transplantation,
s  well  as  the  clinical  and  surgical  treatment  of  such  rhinos-
nusitis.
aterials and methods
his  was  a  retrospective  study  performed  in  a  tertiary
niversity  hospital.  A  total  of  95  patients  with  hemato-
ogic  diseases  submitted  to  HSCT  were  selected.  They  were
reated  at  the  Otorhinolaryngology-Head  and  Neck  Surgery
utpatient  Clinic  from  1996  to  2011.  Inclusion  criteria  were
ll  types  of  HSTC,  adult  patients,  and  any  otorhinolaryngo-
ogy  complaint.  Pediatric  patients  and  those  who  were  not
ubmitted  to  a transplant  were  excluded.
The  variables  studied  were  hematological  disease,  type
f  transplantation,  rhinosinusitis  occurrence  and  GVHD,aranasal  sinuses  and  nasal  endoscopy,  type  of  clinical
reatment,  need  for  sinonasal  surgery,  and  overall  survival
ime.  These  data  were  collected  from  medical  records  and
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Table  1  Frequency  of  hematologic  diseases  of  the  selected
patients.
Hematologic  disease  Frequency  Percentage
CML  45  48.4%
AML 12  13%
ALL 8  8.6%
AA 6  6.5%
NHL 6  6.5%
MM 6  6.5%
Myelodysplasia  4  4.3%
HL 3  3.23%
MS 1  1.08%
PNH 1  1.08%
CLL 1  1.08%
Nefet 93  100%
CML, chronic myeloid leukemia; AML, acute myeloid leukemia;
ALL, acute lymphoblastic leukemia; AA, aplastic anemia; NHL,
non-Hodgkin’s lymphoma; MM, multiple myeloma; HL, Hodgkin’s
Table  2  Rhinosinusitis  (RS)  vs.  type  of  autologous  and  allo-
genic  hematopoietic  stem  cell  transplantation  (HSCT).
With  RS  Without  RS  Total
Allogenic  30  51  81
Autologous  4  9  13
Total 34  60  94
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Endoscopic  sinusectomy  was  performed  in  58%  (20/34)  of
patients  with  rhinosinusitis,  and  approximately  48%  of  these
patients  had  GVHD;  only  9%  did  not  have  GVHD.
Table  3  Nasal  endoscopy  alterations.
Endoscopic  findings  Frequency  Percentage
Normal  29  31%
PR 19  20%
SD 11  12%
ME 11  12%
MR 10  11%
Fungal 5  5%
SD/MR 2  2%
ME/SD 2  2%
PR/ME 2  2%
ME/MR 1  1%
Necrosis  1  1%
SP 1  1%
Total 94  100%lymphoma; MS, multiple sclerosis; PNH, paroxysmal nocturnal
hemoglobinuria; CLL, chronic lymphocytic leukemia; Nefet, N
effective.
examinations  performed  at  the  service.  Records  that  con-
tained  incomplete  data  for  the  statistical  analysis  were
excluded.  Missing  data  were  removed  from  the  calculation
during  the  statistical  analysis  of  each  variable.  Therefore,
the  total  of  some  variables  was  less  than  the  total  sample
number  (95).
The  diagnosis  of  rhinosinusitis  was  established  according
to  the  symptoms  and  signs  on  physical  examination,  in  addi-
tion  to  nasal  endoscopy  results,  according  to  the  Guidelines
on  Rhinosinusitis  of  ABORL-CCF  and  EPOS.10
The  Research  Ethics  Committee  of  UNICAMP  approved
the  study,  and  an  informed  consent  was  obtained  from  all
patients  (088/2001).
Comparisons  were  performed  between  the  variables,
type  of  transplantation,  and  GVHD  with  rhinosinusi-
tis  occurrence,  treatment,  and  survival.  These  variables
were  statistically  analyzed  through  frequency  distribution,
Fisher’s  exact  test,  Kaplan--Meier  curves,  and  Cox  models.
Results
Regarding  hematological  disease,  chronic  myeloid  leukemia
was  the  most  prevalent  disease,  followed  by  acute  myeloid
leukemia  and  acute  lymphocytic  leukemia.  Table  1  shows  the
distribution  of  hematologic  malignancies  in  the  95  patients.
The  type  of  transplantation  most  often  performed  was
the  allogenic  type  (85.26%).  Acute  rhinosinusitis  occurred
in  34  patients,  which  corresponds  to  a  rate  of  36.17%.
There  was  no  significant  difference  in  the  occurrence  of  rhi-
nosinusitis  in  different  autologous  (30%)  or  allogenic  (37%)
transplantations.  The  type  of  HSCT  was  not  associated  with
a  higher  incidence  of  sinusitis  (Table  2).
Nasal  endoscopy  was  performed  in  98.95%  of  patients.
This  examination  showed  results  within  the  normal  range
in  29%  of  cases.  The  most  frequent  alteration  (20%)  found
was  purulent  rhinorrhea  (Table  3).  Alterations  suggestive  of
fungal  infection  were  observed  in  little  more  than  5%  of
patients,  such  as  brownish  or  grayish  mucosa  of  the  anteriorp = 0.764; diagnostic odds ratio = 1.32; confidence interval
(95%) = 0.33--6.38.
asal  septum  and  middle  and  lower  turbinates,  in  addition  to
ecrosis  of  the  nasal  fossa  structures,  mainly  of  the  middle
urbinate  in  1%  of  patients.
The  CT  scan  of  the  paranasal  sinuses  was  performed  in
8.42%  of  patients.  The  homogeneous  opacification  of  the
aranasal  sinus  without  bone  structural  alterations,  regard-
ess  of  the  affected  sinus,  was  the  most  frequent  alteration
approximately  40%),  followed  by  mucosal  edema  in  10%  of
he  CTs  (Table  4).
Approximately  70%  of  the  patients  were  alive  at  the  time
f  the  study  (Table  5).  The  mean  time  of  HSCT  was  8.9  years
4  months--16  years).
The  development  of  GVHD  after  transplantation  occurred
n  30.53%  of  patients.  The  occurrence  of  GVHD  was  not
ssociated  with  higher  mortality  (p  =  0.228).  However,  the
requency  (72%)  and  the  number  of  rhinosinusites  were
ignificantly  higher  in  patients  with  GVHD  (Table  6).  Approx-
mately  28%  of  patients  with  GVHD  had  more  than  two
pisodes  of  rhinosinusitis,  whereas  no  patients  without
VHD  had  rhinosinusitis  recurrence  (Table  7).
The  patients  who  had  GVHD  had  greater  need  for  sur-
ical  treatment  (p  <  0.001)  and  decreased  overall  survival
Table  8  and  Fig.  1).  The  surgical  treatment  performed  was
ndoscopic  sinusectomy  under  general  anesthesia.PR, purulent rhinorrhea; SD, septal deviation; ME, mucosal
edema; MR, mucoid rhinorrhea; SP, septal perforation; Necro-
sis, signs of necrosis of the mucosa and signs of fungal infection
with whitish, gray, or black staining (fungal).
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Table  4  Computed  tomography  (CT)  of  the  paranasal
sinuses  findings.
Frequency  Percentage
CT  of  the  paranasal  sinuses
Normal  15  32%
HO 18  39%
ME 5  11%
AV 3  7%
SD 1  2%
AV/SD 1  2%
AV/ME 1 2%
HO/AV 1 2%
HETO/ME/SD 1  2%
Total 46  100%
HO, homogeneous opacification; ME, mucosal edema; AV,
anatomic variation; SD, septal deviation; HETO, heterogeneous
opacification.
Table  5  Frequency  of  deaths  in  all  patients  submitted  to
hematopoietic  stem  cell  transplantation.
Number  Percent
Alive  66  69%
Dead 29  31%
Total 95  100%
Table  6  Association  of  graft  vs.  host  disease  (GVHD)  with
rhinosinusitis  (RS).
With  RS  Without  RS  Total
With  GVHD 21  8  29
Without GVHD 13  52  65
Total 34  60  94
p < 0.001; odds ratio = 10.17; confidence interval
(95%) = 3.43--33.28.
Table  7  Frequency  between  rhinosinusitis  (RS)  recurrence
and graft  vs.  host  disease  (GVHD).
No  RS  1  RS  2  RS  3  RS  4  RS  Total
With  GVHD  8  15  2  3  1  29
Without  GVHD  52  13  0  0  0  65
Total 60  28  2  3  1  94
Table  8  Association  between  sinonasal  surgical  treatment
and  graft  vs.  host  disease  (GVHD).
With  surgery  Without  surgery  Total
With  GVHD 14  15  29
Without  GVHD  6  60  66
Total 20  75  95
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Figure  1  Overall  survival  without  graft  vsp < 0.001; odds ratio = 9.05; confidence interval
(95%) = 2.73--33.98.
iscussion
he  increased  number  of  immunosuppressed  patients  as  a
esult  of  advancements  in  medicine  in  the  treatment  of
alignant  neoplasms,  and  degenerative  and  autoimmune
iseases  has  simultaneously  provided  greater  experience  in
he  management  of  these  cases.
Patients  undergoing  transplantations  suffer  several
reparatory  organic  modifications  and  remain  immunosup-
ressed  during  this  process  for  a variable  period  of  time.1--5,7
he  allogenic  HSCT  may  or  may  not  be  myeloablative,  which
auses  increased  immunosuppression  in  patients.1 In  this
tudy,  there  was  a higher  number  of  allogenic  transplanta-
ions;  however,  the  percentage  of  myeloablative  procedures
as  not  obtained.
The  frequency  of  rhinosinusitis  coincided  with  the  post-
SCT  estimate  described  in  the  literature  (36.7%),  but  was
lightly  lower  than  that  in  the  previous  study  (42%)  per-
ormed  in  this  same  service.2,3,5,8 This  can  be  explained
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14. Billings KR, Lowe LH, Aquino VM, Biavati MJ. Screening sinus CT
scans in pediatric bone marrow transplant patients. Int J Pediatr
Otorhinolaryngol. 2000;52:253--60.Sinonasal  disorders  in  hematopoietic  stem  cell  transplantati
by  the  greater  care  given  to  these  patients  before  trans-
plantation,  or  lower  myeloablation  during  the  current  HSCT
process.  As  no  data  were  obtained  regarding  myeloablation,
the  latter  association  cannot  be  explained.  However,  the
frequency  of  rhinosinusitis  remains  higher  when  compared
to  immunocompetent  patients  (5--15%).10
Anterior  rhinoscopy  is  inadequate  for  the  appropriate
sinonasal  assessment  of  these  transplanted  patients.  Nasal
endoscopy  is  the  ideal  and  essential  examination  to  attain  a
correct  and  early  diagnosis  of  rhinosinusitis,  both  pre-  and
post-HSCT.  Endoscopic  assessment  can  evaluate  the  char-
acteristics  of  secretion  and  the  mucosa.  Thus,  it  better
suggests  the  etiologic  factor  (bacterial,  viral,  or  fungal)  and
allows  for  early  treatment  of  sinonasal  disease.  It  is  notewor-
thy  that  the  sign  of  necrosis  or  brownish  or  grayish  mucosa,
mainly  in  the  middle  turbinate  and  anterior  nasal  septum,
suggests  invasive  fungal  infection.4,5,7,10,15
Computed  tomography  (CT)  of  the  paranasal  sinuses  is
a  specific  examination,  in  spite  of  its  low  sensitivity,  as  it
does  not  differentiate  the  type  of  secretion  (purulent  or
mucoid).  It  also  does  not  show  specific  signs  of  invasive  fun-
gal  sinusitis  in  the  initial  stage  of  the  disease.  However,
in  immunosuppressed  patients,  CT  assists  in  the  manage-
ment  of  unfavorable  cases  and  is  crucial  in  the  assessment
of  rhinosinusitis  complications.11--14
The  literature  shows  controversial  opinions  regarding  the
performance  of  CT  pre-HSCT.  Billings  showed  that  CT  of
the  paranasal  sinuses  before  transplantation  may  be  useful
for  the  prevention  of  rhinosinusitis  post-HSCT  in  children.14
However,  Arulrajah  argued  that  the  symptoms  of  rhinor-
rhea,  cough,  and  nasal  congestion  have  similar  importance
to  the  CT  results,  with  no  need  for  CT  when  these  symptoms
exist.12 Kasow  suggested  the  performance  of  preventive  CT
of  the  paranasal  sinuses  before  HSCT  in  children  due  to  the
alterations  found  in  the  examinations,  although  these  were
not  directly  related  to  the  child’s  symptoms.13
Ortiz  showed  that  CT  pre-HSCT  in  adults  does  not  pre-
dict  post-HSCT  sinusitis;  and  anatomical  variations  do  not
predispose  to  rhinosinusitis  after  HSCT,  but  contribute  to
post-HSCT  rhinosinusitis  severity.11 Therefore,  performing
CT  of  the  paranasal  sinuses  prior  to  HSCT  is  suggested  only
when  the  patient  has  chronic  sinonasal  symptoms  or  acute
rhinosinusitis  with  unfavorable  evolution.  After  the  HSCT,
this  examination  would  be  effective  in  cases  refractory  to
medical  treatment  or  suspected  cases  of  complications,
either  fungal  or  bacterial,  in  order  to  highlight  specific
causes  blocking  ostial  drainage,  anatomical  variations,  or
invasion  of  adjacent  structures.
The  frequency  of  GVHD  found  in  the  study  (30%)  was
lower  than  that  reported  in  the  literature  (50%).5,8 These
patients  were  more  susceptible  to  the  development  and
recurrence  of  rhinosinusitis,  which  is  in  agreement  with  the
literature.2--5,8,9
A  previous  study  showed  that  in  addition  to  immuno-
suppression,  there  is  a  change  in  the  ultrastructure  of  the
respiratory  ciliated  pseudo-stratified  epithelium  and  micro-
scopic  changes  on  the  epithelial  surface,  such  as  squamous
metaplasia  and  fibrosis.  Therefore,  there  must  be  a  change
in  mucociliary  clearance  that  would  predispose  to  recur-
rence  of  the  rhinosinusitis.9 Thus,  these  patients  with  GVHD
have  a  greater  need  of  surgical  treatment  for  recurrent  rhi-
nosinusitis  control.8,9
1289
onclusion
atients  who  received  HSCT  have  a  higher  incidence  of
inusitis  when  compared  to  immunocompetent  patients.
The  type  of  transplantation  does  not  influence  the  fre-
uency  of  rhinosinusitis;  however,  chronic  GVHD  appears  to
ctually  be  an  aggravating  factor.
Chronic  GVHD  was  associated  with  a greater  need  for
inus  surgery  to  control  rhinosinusitis.  Additionally,  these
atients  with  chronic  GVHD  showed  decreased  overall  sur-
ival.
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